Clinical Trial Update: Safety Study of High Doses of Zinc in ALS Patients [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/Phase 2 safety study evaluating high-dose zinc in patients with amyotrophic lateral sclerosis. The study's spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Phoenix Neurological Associates, LTD | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED